# Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis

Study · id `cardio:ct-nct02628899` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02628899](<https://clinicaltrials.gov/study/NCT02628899>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02628899

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 277 participants.

## Technical summary

Registry record NCT02628899. Non-randomized; no masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2023-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 277 participants (enrolled count; ClinicalTrials.gov record NCT02628899, source copy `cardio:ctgov-nct02628899-2024-05-16`, retrieved 2026-10-26)
- Started: 2016-01 (actual) (ClinicalTrials.gov record NCT02628899, source copy `cardio:ctgov-nct02628899-2024-05-16`, retrieved 2026-10-26)
- Primary completion: 2023-01 (actual) (ClinicalTrials.gov record NCT02628899, source copy `cardio:ctgov-nct02628899-2024-05-16`, retrieved 2026-10-26)
- Completion: 2023-01 (actual) (ClinicalTrials.gov record NCT02628899, source copy `cardio:ctgov-nct02628899-2024-05-16`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02628899, source copy `cardio:ctgov-nct02628899-2024-05-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02628899-2024-05-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
- Condition: Aortic Stenosis
- Intervention (Device): Transfemoral TAVR
- Intervention (Device): SAVR
- Lead sponsor: Medstar Health Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Medstar Health Research Institute (`cardio:org-medstar-health-research-institute`)

## Provenance

Content hash: 3fe26d3018fd7f6f296406c830f2ffd93b52ea5184a29d6d521a1ff286d6ab85
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
